China Shineway Pharmaceutical Sustainability Profile
China Shineway Pharmaceutical Group Limited, commonly referred to as Shineway Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1997, the company has made significant strides in the development and manufacturing of traditional Chinese medicine and modern pharmaceuticals, with a strong operational presence across Asia and beyond. Shineway Pharmaceutical is renowned for its core products, including herbal medicines and innovative therapeutic solutions, which are distinguished by their quality and efficacy. The company has achieved notable milestones, such as receiving various certifications for its manufacturing processes, solidifying its reputation in the market. With a commitment to research and development, Shineway continues to enhance its product offerings, positioning itself as a leader in the pharmaceutical sector and contributing to the global healthcare landscape.
DitchCarbon Score
How does China Shineway Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
China Shineway Pharmaceutical's score of 19 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
China Shineway Pharmaceutical's reported carbon emissions
In 2022, China Shineway Pharmaceutical, headquartered in CN, reported total carbon emissions of approximately 141,380,020 kg CO2e. This figure includes 87,499,000 kg CO2e from Scope 1 emissions, 30,190,000 kg CO2e from Scope 2, and 23,691,000 kg CO2e from Scope 3. The company's emissions data is cascaded from its parent company, China Shineway Pharmaceutical Group Limited, which provides a comprehensive overview of its carbon footprint. For the year 2021, the company recorded total emissions of about 117,794,000 kg CO2e, with Scope 1 emissions at 76,087,000 kg CO2e, Scope 2 at 16,885,000 kg CO2e, and Scope 3 at 24,822,000 kg CO2e. The emissions intensity per employee was reported at 34,220 kg CO2e in 2022, indicating a focus on measuring and managing emissions relative to workforce size. Despite the detailed emissions reporting, China Shineway Pharmaceutical has not set specific reduction targets or initiatives as part of its climate commitments. The absence of SBTi (Science Based Targets initiative) reduction targets suggests a need for further development in their climate strategy. The company is currently classified as a current subsidiary of China Shineway Pharmaceutical Group Limited, which influences its emissions reporting and performance metrics.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Scope 1 | 117,620,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 2 | 8,186,000 | 00,000,000 | 0,000,000 | 0,000,000 | 00,000,000 |
| Scope 3 | 27,604,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
How Carbon Intensive is China Shineway Pharmaceutical's Industry?
How Carbon Intensive is China Shineway Pharmaceutical's Location?
China Shineway Pharmaceutical's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
China Shineway Pharmaceutical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
